TARKA

LOE Approaching

trandolapril; verapamil hydrochloride

NDAORALTABLET, EXTENDED RELEASE
Approved
Oct 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT01127139N/ACompleted

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension

Started Apr 2010
3,828 enrolled
Essential Hypertension
NCT01079195N/ACompleted

Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus

Started Oct 2007
15,436 enrolled
Hypertension
NCT00235001Phase 4Completed

Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

Started Jun 2004
120 enrolled
Hypertension
NCT00234858Phase 4Completed

Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)

Started Mar 2004
280 enrolled
HypertensionMetabolic Syndrome
NCT00234871Phase 4Completed

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Started Jan 2004
357 enrolled
HypertensionDiabetesProteinuria
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.